CBG is a non-intoxicating cannabinoid that may well be the next cannabinoid to become the focus of medical cannabis research.
As well as providing various cannabis strains with delicious sensory profiles, pinene is also a proven player in the medical cannabis field.
Unlike most cannabinoids, cannabinol (CBN) rarely results from the decarboxylation of its acid form (CBNA) and performs similarly to THC.
Beta-Caryophyllene is a rare terpene as it is one of the first non-cannabinoids to directly activate cannabinoid receptors.
We spoke exclusively to Ethan Russo who believes that many common diseases stem from clinical endocannabinoid deficiency.
Myrcene functions as a sedative, an analgesic, a systemic anti-inflammatory, an antibiotic, and a cancer cell antagonist.
What sets THCV apart from the other cannabinoids is it has the ability to suppress appetite, as studies are demonstrating.
The little research available suggests that some parts of cannabis may be more helpful than others for treating chronic kidney disease.
The Honest Marijuana Company is currently working on a nano-cannabinoid technology that will deliver cannabinoids in a time-released fashion.
Nate Pennington from Humboldt Seed Company talks us through the newest weed strains that we're excited to see hit the market in 2019.